Administration of cyclophosphamide to rats induces pica and potentiates 5-hydroxytryptamine synthesis in the intestine without causing severe intestinal injury

The role of nitric oxide in small intestine differs between a single and a consecutive administration of methotrexate to rats

(2020) Saki Shiga et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Role of Nitric Oxide in the Change of 5-Hydroxytryptamine Synthesis in the Intestine by a Consecutive Administration of Methotrexate to Rats

(2020) Takuji Machida et al.   PHARMACOLOGY

Nitric oxide plays a critical role in methotrexate-induced hyperplasia of enterochromaffin cells containing 5-hydroxytryptamine in rat small intestine

(2019) Yuho Takano et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Enterochromaffin cell hyperplasia in the gut: Factors, mechanism and therapeutic clues

(2019) Hong-yan Qin et al.   LIFE SCIENCES

Cisplatin increases the number of enterochromaffin cells containing substance P in rat intestine

(2018) Yusuke Obara et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Methotrexate causes acute hyperplasia of enterochromaffin cells containing substance P in the intestinal mucosa of rats

(2017) Takuji Machida et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Function of capric acid in cyclophosphamide-induced intestinal inflammation, oxidative stress, and barrier function in pigs

(2017) Sang In Lee et al.   Scientific Reports

Notch regulation of gastrointestinal stem cells

(2016) Elise S. Demitrack et al.   JOURNAL OF PHYSIOLOGY-LONDON

Administration of Olanzapine as an Antiemetic Agent Changes Glucose Homeostasis in Cisplatin-Treated Rats

(2015) Maiko Machida et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Methotrexate causes a change in intestinal 5-hydroxytryptamine metabolism in rats

(2014) Yuho Takano et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study

(2013) Francesco Russo et al.   BMC CANCER

The changes induced by cyclophosphamide in intestinal barrier and microflora in mice

(2013) Jin Yang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cisplatin causes over-expression of tachykinin NK1 receptors and increases ERK1/2- and PKA‐ phosphorylation during peak immediate- and delayed-phase emesis in the least shrew (Cryptotis parva) brainstem

(2012) Nissar A. Darmani et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

(2011) Richard Hargreaves et al.   Annals of the New York Academy of Sciences

Effects of Cyclophosphamide on the Kaolin Consumption (Pica Behavior) in Five Strains of Adult Male Rats

(2011) Atsushi TOHEI et al.   JOURNAL OF VETERINARY MEDICAL SCIENCE

Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients

(2010) Toshiaki Takahashi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Mouse atonal homolog 1 directs intestinal progenitors to secretory cell rather than absorptive cell fate

(2010) Kelli L. VanDussen et al.   DEVELOPMENTAL BIOLOGY

Time-course analysis of pica in rats using an automatic feeding monitoring system

(2010) Kouichi Yamamoto et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

BURN-INDUCED GUT BARRIER INJURY IS ATTENUATED BY PHOSPHODIESTERASE INHIBITION

(2009) Todd W. Costantini et al.   SHOCK

Anti-inflammatory drugs ameliorate opposite enzymatic changes in ileal 5-hydroxytryptamine metabolism in the delayed phase after cisplatin administration to rats

(2008) Chuanxia Ju et al.   EUROPEAN JOURNAL OF PHARMACOLOGY